PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
iHealthcareAnalyst, Inc.

Press Release


Receive press releases from iHealthcareAnalyst, Inc.: By Email RSS Feeds:

Global Atrial Fibrillation Market to Reach USD 13.6 Billion by 2020


Atrial Fibrillation Market – Global Pharmacological and Non-Pharmacological Treatments Analysis and Forecast 2013-2020

Maryland Heights, MO, June 28, 2016 --(PR.com)-- A new market research report published by iHealthcareAnalyst, Inc., estimates Atrial Fibrillation Market – Global Pharmacological and Non-Pharmacological Treatments Analysis and Forecast 2013-2020, as the global atrial fibrillation market growing at the rate of 11.8% CAGR and estimated to reach USD 13.6 Billion by 2020 due to rising geriatric population and elderly diseases.

Browse Atrial Fibrillation Market – Global Pharmacological and Non-Pharmacological Treatments Analysis and Forecast 2013-2020 at http://www.ihealthcareanalyst.com/report/atrial-fibrillation-market/

Atrial fibrillation (A-Fib or AF) involves quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Treatments for atrial fibrillation may include medications and other interventions to try to alter the heart's electrical system. The atrial fibrillation market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on treatment type (pharmacological - anti-arrhythmic drugs, anti-coagulant drugs and non-pharmacological - catheter ablation based on cryoablation, HIFU, laser, microwave and radiofrequency, maze surgery, and electric cardioversion), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management.

The global atrial fibrillation market is segmented as:
1. Treatment Type
1.1. Pharmacological Treatment
1.1.1.Anti-Arrhythmic Drugs
1.1.2. Anti-Coagulant Drugs
1.2. Non-Pharmacological Treatment
1.2.1. Catheter Ablation
1.2.1.1. Cryoablation Based
1.2.1.2. HIFU (High Intensity Focused Ultrasound) Based
1.2.1.3. Laser Based
1.2.1.4. Microwave Based
1.2.1.5. Radiofrequency Based
1.2.2. Maze Surgery
1.2.3. Electric Cardioversion

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. AtriCure, Inc.
3.2. Biosense Webster, Inc.
3.3. Boehringer Ingelheim GmbH
3.4. Boston Scientific Corporation
3.5. Bristol-Myers Squibb Corporation
3.6. CardioFocus, Inc.
3.7. Endoscopic Technologies, Inc.
3.8. Sanofi Aventis
3.9. St. Jude Medical, Inc.
3.10. Johnson and Johnson Ltd.

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Information
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
Contact
http://www.ihealthcareanalyst.com/

Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.
Promote Your Business